Review of 'Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series'

Reviewer: arnab kumar banerjee

Publication date of review: 2021-07-22

Bookmark

arnab kumar banerjee5

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesCrossref ScienceOpen

cases show a significant result

Average rating:	    Rated 5 of 5.
Level of importance:	    Rated 5 of 5.
Level of validity:	    Rated 5 of 5.
Level of completeness:	    Rated 5 of 5.
Level of comprehensibility:	    Rated 5 of 5.
Competing interests:	None

Reviewed article

Record: found
Abstract: not found
Article: not found

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William Werbel, Brian J. Boyarsky, Michael Ou … (2021)

0 comments Cited 179 times     Rated -3 of 5. – based on 1 reviews

Bookmark

Review information

DOI:: 10.14293/S2199-1006.1.SOR-UNCAT.A8252023.v1.RSAAWI

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com.

Review text

one good news is that the antibodies are increased. but the limitation is hurting. b cell, t cell are important and antibody neutralization is also important. it is like you set a fire without knowing how to extinguish the fire. later these increased antibody may cause another different kind of trouble.

Comments

Comment on this review

Version and Review History

Reviewed by arnab kumar banerjee